CNCE

Concert Pharmaceuticals, Inc.

Delisted

CNCE was delisted on the 3rd of March, 2023.

67 hedge funds and large institutions have $178M invested in Concert Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-1
Holders Change %
-1.47%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
16
Increased
29
Reduced
13
Closed
17
Calls
$152K
Puts
Net Calls
+$152K
Net Calls Change
+$152K
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
76
Renaissance Technologies
New York
-$453K -29,900 Closed
Two Sigma Advisers
77
Two Sigma Advisers
New York
-$415K -27,400 Closed
WMSA
78
Weiss Multi-Strategy Advisers
New York
-$379K -25,000 Closed
MCM
79
Moore Capital Management
New York
-$379K -25,000 Closed
BG
80
BlackRock Group
United Kingdom
-$353K -23,299 Closed
BCM
81
BlueCrest Capital Management
Jersey
-$341K -22,542 Closed
Jane Street
82
Jane Street
New York
-$308K -20,330 Closed
Citadel Advisors
83
Citadel Advisors
Florida
-$293K -19,333 Closed
BJ
84
BlackRock Japan
Japan
-$40K -2,663 Closed